Clinical trials: NMES

Neonatal Brachial Plexus Palsy

NMES Efficacy on Patients With NBPP

• Completed
• Age: 3 to 9 months
• Medical device
• Results posted

Neonatal Brachial Plexus Palsy (NBPP), characterized by weakness and sensory loss in the affected arm, results from damage in the prenatal period to the nerves extending from the spine to the arm.

Trial name

NCT01999465

Testing

Standard NMES device

Where

United States

Volunteers

20 people

Sponsor

University of Michigan